Logo of annrheumdAnnals of the Rheumatic DiseasesVisit this articleSubmit a manuscriptReceive email alertsContact usBMJ
Ann Rheum Dis. Aug 1989; 48(8): 662–666.
PMCID: PMC1003843

Treatment of polymyalgia rheumatica and giant cell arteritis. II. Relation between steroid dose and steroid associated side effects.


In a prospective study of 74 patients and a retrospective study of 35 patients with polymyalgia rheumatica/giant cell arteritis steroid related side effects occurred in at least one third of patients, and in two thirds if weight gain was included. Side effects were significantly related to an initial prednisolone dose of more than 30 mg and to the cumulative prednisolone dose. Patients taking a mean daily dose of 5 mg prednisolone or less were significantly less likely to develop side effects.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (627K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Fainaru M, Friedman G, Friedman B. Temporal arteritis in Israel. A review of 47 patients. J Rheumatol. 1979 May-Jun;6(3):330–335. [PubMed]
  • Graham E, Holland A, Avery A, Russell RW. Prognosis in giant-cell arteritis. Br Med J (Clin Res Ed) 1981 Jan 24;282(6260):269–271. [PMC free article] [PubMed]
  • Spiera H, Davison S. Long-term follow-up of polymyalgia rheumatica. Mt Sinai J Med. 1978 Mar-Apr;45(2):225–229. [PubMed]
  • Huston KA, Hunder GG, Lie JT, Kennedy RH, Elveback LR. Temporal arteritis: a 25-year epidemiologic, clinical, and pathologic study. Ann Intern Med. 1978 Feb;88(2):162–167. [PubMed]
  • Ayoub WT, Franklin CM, Torretti D. Polymyalgia rheumatica. Duration of therapy and long-term outcome. Am J Med. 1985 Sep;79(3):309–315. [PubMed]
  • Bengtsson BA, Malmvall BE. Prognosis of giant cell arteritis including temporal arteritis and polymyalgia rheumatica. A follow-up study on ninety patients treated with corticosteroids. Acta Med Scand. 1981;209(5):337–345. [PubMed]
  • von Knorring J. Treatment and prognosis in polymyalgia rheumatica and temporal arteritis. A ten-year survey of 53 patients. Acta Med Scand. 1979;205(5):429–435. [PubMed]
  • Behn AR, Perera T, Myles AB. Polymyalgia rheumatica and corticosteroids: how much for how long? Ann Rheum Dis. 1983 Aug;42(4):374–378. [PMC free article] [PubMed]
  • Myles AB. Polymyalgia rheumatica and giant cell arteritis: a seven-year survey. Rheumatol Rehabil. 1975 Nov;14(4):231–235. [PubMed]
  • Jones JG, Hazleman BL. Prognosis and management of polymyalgia rheumatica. Ann Rheum Dis. 1981 Feb;40(1):1–5. [PMC free article] [PubMed]
  • Kyle V, Hazleman BL. Treatment of polymyalgia rheumatica and giant cell arteritis. I. Steroid regimens in the first two months. Ann Rheum Dis. 1989 Aug;48(8):658–661. [PMC free article] [PubMed]
  • Bigger JF, Palmberg PF, Becker B. Increased cellular sensitivity to glucocorticoids in primary open-angle glaucoma. Invest Ophthalmol. 1972 Oct;11(10):832–837. [PubMed]
  • Becker B, Podos SM, Asseff CF, Cooper DG. Plasma cortisol suppression in glaucoma. Am J Ophthalmol. 1973 Jan;75(1):73–76. [PubMed]
  • Becker B, Shin DH, Palmberg PF, Waltman SR. HLA antigens and corticosteroid response. Science. 1976 Dec 24;194(4272):1427–1428. [PubMed]
  • Conn HO, Blitzer BL. Nonassociation of adrenocorticosteroid therapy and peptic ulcer. N Engl J Med. 1976 Feb 26;294(9):473–479. [PubMed]
  • Messer J, Reitman D, Sacks HS, Smith H, Jr, Chalmers TC. Association of adrenocorticosteroid therapy and peptic-ulcer disease. N Engl J Med. 1983 Jul 7;309(1):21–24. [PubMed]
  • Wadman B, Werner I. Thromboembolic complications during corticosteroid treatment of temporal arteritis. Lancet. 1972 Apr 22;1(7756):907–907. [PubMed]
  • Uriu SA, Reinecke RD. Temporal arteritis, steroid therapy, and pulmonary emboli. Arch Ophthalmol. 1973 Nov;90(5):355–357. [PubMed]
  • BOURA AL, COPP FC, GREEN AF. Amidines as adrenergic neurone blocking agents. Nature. 1962 Sep 22;195:1213–1214. [PubMed]
  • David DS, Grieco MH, Cushman P., Jr Adrenal glucocorticoids after twenty years. A review of their clinically relevant consequences. J Chronic Dis. 1970 Mar;22(10):637–711. [PubMed]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Group


Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...


  • Compound
    PubChem Compound links
  • MedGen
    Related information in MedGen
  • PubMed
    PubMed citations for these articles
  • Substance
    PubChem Substance links

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...